Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Avita Medical, Inc. (RCEL) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Avita Medical, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1762303.
Total stock buying since 2020: $550,098.
Total stock sales since 2020: $2,755,967.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 36,000 | $234,710 | 0 | $0 | 0 | $0 |
| 2024 | 2,711 | $40,299 | 0 | $0 | 0 | $0 |
| 2023 | 16,450 | $240,806 | 8,156 | $116,516 | 0 | $0 |
| 2021 | 1,066 | $18,207 | 34,220 | $630,618 | 0 | $0 |
| 2020 | 693 | $16,076 | 74,989 | $2,008,833 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 24,000 | $113,660 | 0 | $0 | 0 | $0 |
| 2025-02 | 12,000 | $121,050 | 0 | $0 | 0 | $0 |
| 2024-12 | 1,461 | $18,543 | 0 | $0 | 0 | $0 |
| 2024-02 | 1,250 | $21,756 | 0 | $0 | 0 | $0 |
| 2023-12 | 1,450 | $17,167 | 3,963 | $50,099 | 0 | $0 |
| 2023-11 | 7,000 | $83,740 | 0 | $0 | 0 | $0 |
| 2023-08 | 7,000 | $123,750 | 4,193 | $66,417 | 0 | $0 |
| 2023-06 | 1,000 | $16,149 | 0 | $0 | 0 | $0 |
| 2021-09 | 1,066 | $18,207 | 11,220 | $232,029 | 0 | $0 |
| 2021-06 | 0 | $0 | 23,000 | $398,589 | 0 | $0 |
| 2020-09 | 0 | $0 | 74,989 | $2,008,833 | 0 | $0 |
| 2020-07 | 693 | $16,076 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-28 | Mcnamara Robert | Buy | 10,000 | 4.50 | 45,000 |
| 2025-08-26 | O'toole David D (CFO) | Buy | 2,000 | 4.52 | 9,040 |
| 2025-08-19 | Mcnamara Robert | Buy | 10,000 | 5.00 | 50,000 |
| 2025-08-12 | O'toole David D (CFO) | Buy | 2,000 | 4.81 | 9,620 |
| 2025-02-20 | O'toole David D (CFO) | Buy | 1,000 | 9.90 | 9,900 |
| 2025-02-20 | Mcnamara Robert | Buy | 10,000 | 10.09 | 100,900 |
| 2025-02-19 | O'toole David D (CFO) | Buy | 1,000 | 10.25 | 10,250 |
| 2024-12-09 | Crowe Suzanne | Buy | 486 | 13.15 | 6,390 |
| 2024-12-05 | O'toole David D (CFO) | Buy | 975 | 12.46 | 12,153 |
| 2024-02-28 | O'toole David D (CFO) | Buy | 1,250 | 17.41 | 21,756 |
| 2023-12-26 | Corbett James (CEO) | Sale | 1,445 | 13.29 | 19,204 |
| 2023-12-13 | Cook Jeremy Curnock | Sale | 2,518 | 12.27 | 30,895 |
| 2023-12-12 | O'toole David D (CFO) | Buy | 950 | 12.45 | 11,827 |
| 2023-12-01 | O'toole David D (CFO) | Buy | 500 | 10.68 | 5,340 |
| 2023-11-21 | O'toole David D (CFO) | Buy | 2,000 | 10.28 | 20,560 |
| 2023-11-16 | O'toole David D (CFO) | Buy | 1,000 | 12.15 | 12,150 |
| 2023-11-15 | O'toole David D (CFO) | Buy | 2,000 | 12.85 | 25,700 |
| 2023-11-14 | O'toole David D (CFO) | Buy | 1,000 | 12.88 | 12,880 |
| 2023-08-21 | Shiroma Donna (General Counsel) | Sale | 4,193 | 15.84 | 66,417 |
| 2023-08-16 | O'toole David D (CFO) | Buy | 2,000 | 17.05 | 34,110 |
| 2023-08-15 | O'toole David D (CFO) | Buy | 5,000 | 17.93 | 89,640 |
| 2023-06-20 | O'toole David D (CFO) | Buy | 1,000 | 16.15 | 16,149 |
| 2021-09-20 | Crowe Suzanne (Director) | Buy | 1,066 | 17.08 | 18,207 |
| 2021-09-01 | Perry Michael S (Chief Executive Officer) | Sale | 11,220 | 20.68 | 232,029 |
| 2021-06-02 | Perry Michael S (Chief Executive Officer) | Sale | 23,000 | 17.33 | 398,589 |
| 2020-09-16 | Perry Michael S (Chief Executive Officer) | Sale | 9,000 | 27.41 | 246,690 |
| 2020-09-15 | Perry Michael S (Chief Executive Officer) | Sale | 23,769 | 27.23 | 647,229 |
| 2020-09-14 | Perry Michael S (Chief Executive Officer) | Sale | 15,092 | 26.99 | 407,333 |
| 2020-09-11 | Perry Michael S (Chief Executive Officer) | Sale | 20,000 | 26.02 | 520,400 |
| 2020-09-10 | Perry Michael S (Chief Executive Officer) | Sale | 7,128 | 26.26 | 187,181 |
| 2020-07-17 | Mcintyre David (Chief Financial Officer) | Buy | 393 | 22.70 | 8,921 |
| 2020-07-16 | Mcintyre David (Chief Financial Officer) | Buy | 300 | 23.85 | 7,155 |
Insider trading activities including stock purchases, stock sales, and option exercises of RCEL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Avita Medical, Inc. (symbol RCEL, CIK number 1762303) see the Securities and Exchange Commission (SEC) website.